ASTHMA CONTROL OUTCOMES AMONG INPATIENTS AT CAM KHE REGIONAL MEDICAL CENTER, PHU THO PROVINCE

Kim Sơn Trần1, , Kim Liên Phạm2
1 Trung tâm Y tế khu vực Cẩm Khê
2 Trường Đại học Y Dược Thái Nguyên

Main Article Content

Abstract

Objective: To analyze asthma control outcomes based on the Asthma Control Test (ACT) one month after hospital discharge, and to identify factors associated with poor control.


Subjects and methods: A cross-sectional study with longitudinal follow-up was conducted on 90 patients diagnosed with asthma according to GINA 2024 criteria, hospitalized at Cam Khe Regional Medical Center, Phu Tho Province, from June 2025 to June 2026, using a total/convenience sampling method. Asthma control was assessed using the ACT questionnaire one month after discharge.


Results: Mean age was 56.5 ± 15.8 years (range 16–83); males accounted for 56.7%. GINA step 3 accounted for 20.0% of patients; the dyspnea-predominant phenotype accounted for 90.0%. After 1 month of treatment, the rate of good control reached 77.8% (mean ACT score 21.3 ± 1.9). More than 2 exacerbations/year (72.6% vs. 100.0% good control in the group with ≤ 2 exacerbations/year; p = 0.010), GINA step 3 (50.0% vs. 15.3% poor control; p = 0.002), and severe exacerbation (53.3% vs. 16.0%; p = 0.004) were significantly associated with poor control. Multivariable analysis (Firth logistic regression) identified GINA step 3 (OR = 6.65; 95%CI: 2.00–22.06; p = 0.002) and number of exacerbations/year (OR = 1.83; 95%CI: 1.02–3.28; p = 0.043) as two independent risk factors. Absolute eosinophil count showed no predictive value (ROC curve AUC = 0.446; 95%CI: 0.313–0.580).


Conclusion: Asthma control one month after hospitalization reached a fairly good rate at this regional healthcare facility. Severe asthma (GINA step) was the most important independent predictor of poor control, whereas absolute blood eosinophil count showed no prognostic value in this study sample.

Article Details

References

1. World Health Organization. Asthma fact sheet. Truy cập tại: https://www.who.int/news-room/fact-sheets/detail/asthma (2023).
2. Global Initiative for Asthma (GINA). Asthma Management and Prevention for Adults, Adolescents and Children 6–11 Years: A Summary Guide for Health Professionals. Fontana, WI: GINA (2025).
3. Nathan, R. A., Sorkness, C. A., Kosinski, M. et al. Development of the Asthma Control Test: A Survey for Assessing Asthma Control. Journal of Allergy and Clinical Immunology, 113, 59-65 (2004).
4. Nguyễn Ngọc Hân, Nguyễn Thị Hồng Trân & Đỗ Thị Thanh Trà. Kết quả kiểm soát hen phế quản và một số yếu tố liên quan đến kiểm soát hen phế quản không hoàn toàn. Tạp chí Y Dược học Cần Thơ, số 74, 126-131 (2024).
5. Eriksson, S. et al. Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study. Journal of Asthma and Allergy, 17, 621-632 (2024).
6. Torchyan, A. A. Asthma control in Saudi Arabia: Gender implications. Allergy and Asthma Proceedings, 38, 47-53 (2017).
7. Nguyen Nhu, V., Le An, P. & Chavannes, N. H. Combination of Fractional Exhaled Nitric Oxide (FeNO) Level and Asthma Control Test (ACT) in Detecting GINA-Defined Asthma Control in Treated Asthmatic Patients in Vietnam. Canadian Respiratory Journal, 2020, 5735128 (2020).
8. Bosnic-Anticevich, S., Bender, B. G., Shuler, M. T., Hess, M. & Kocks, J. W. H. Recognizing and Tackling Inhaler Technique Decay in Asthma and Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice. The Journal of Allergy and Clinical Immunology: In Practice, 11, 2355-2364 (2023).